MetaADEDB 2.0 @ LMMD
Carbamide Peroxide
(AQLJVWUFPCUVLO-UHFFFAOYSA-N)
Structure
SMILES
NC(=O)N.OO
Type(s)
Approved
Molecular Formula:
CH6N2O3
Molecular Weight:
94.070
Log P:
0.4418
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
4
TPSA:
109.57
CAS Number(s):
124-43-6
Synonym(s)
1.
Carbamide Peroxide
2.
Perhydrol Urea
3.
Urea Hydrogen Peroxide
4.
Urea Peroxide
5.
Hydrogen Peroxide, Urea
External Link(s)
MeSHD000077463
PubChem Compound31294
ChEBI75178
CHEMBLCHEMBL3184026
DrugBankDB11129
KEGGdr:D03383
Therapeutic Target DatabaseD01BQK
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1DeafnessFAERS: 98OFFSIDES
US FAERS
2Ear discomfortFAERS: 74OFFSIDES
US FAERS
3Drug administration errorFAERS: 21OFFSIDES
US FAERS
4TinnitusFAERS: 18OFFSIDES
US FAERS
5Expired drug administeredFAERS: 11OFFSIDES
US FAERS
6Drug ineffectiveFAERS: 10US FAERS
7Tympanic Membrane PerforationFAERS: 10OFFSIDES
US FAERS
8Auricular swellingFAERS: 9OFFSIDES
US FAERS
9DizzinessFAERS: 7US FAERS
10Product quality issueFAERS: 6OFFSIDES
US FAERS
11Wrong technique in drug usage processFAERS: 6US FAERS
12Ear congestionFAERS: 4US FAERS
13NervousnessFAERS: 4US FAERS
14AnxietyFAERS: 3US FAERS
15DiscomfortFAERS: 3US FAERS
16ErythemaFAERS: 3US FAERS
17Feeling abnormalFAERS: 3US FAERS
18HeadacheFAERS: 3US FAERS
19PainFAERS: 3US FAERS
20Expired product administeredFAERS: 2US FAERS
21HyperacusisFAERS: 2US FAERS
22Hypoaesthesia facialFAERS: 2US FAERS
23Instillation site erythemaFAERS: 2US FAERS
24Instillation site painFAERS: 2US FAERS
25Otitis MediaFAERS: 2US FAERS
26Pharmaceutical product complaintFAERS: 2US FAERS
27PruritusFAERS: 2US FAERS
28SinusitisFAERS: 2US FAERS
29SomnolenceFAERS: 2US FAERS
30Accidental drug intake by childFAERS: 1OFFSIDES
US FAERS
31Accidental exposure to productFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
32Adverse eventFAERS: 1US FAERS
33Application site dischargeFAERS: 1US FAERS
34Application site discomfortFAERS: 1US FAERS
35Application site infectionFAERS: 1US FAERS
36BlindnessFAERS: 1US FAERS
37CheilitisFAERS: 1US FAERS
38Chemical injuryFAERS: 1US FAERS
39ClaustrophobiaFAERS: 1US FAERS
40Drug prescribing errorFAERS: 1US FAERS
41DysacusisFAERS: 1US FAERS
42DysarthriaFAERS: 1US FAERS
43DysgeusiaFAERS: 1US FAERS
44DysphoniaFAERS: 1OFFSIDES
US FAERS
45EpistaxisFAERS: 1US FAERS
46Eye irritationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
47Facial paralysisFAERS: 1US FAERS
48Head titubationFAERS: 1US FAERS
49HypersensitivityFAERS: 1US FAERS
50Incorrect dose administeredFAERS: 1US FAERS
51Incorrect route of drug administrationFAERS: 1US FAERS
52Incorrect route of product administrationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
53InflammationFAERS: 1US FAERS
54Instillation site complicationFAERS: 1US FAERS
55Instillation site swellingFAERS: 1US FAERS
56LacerationFAERS: 1US FAERS
57MalaiseFAERS: 1US FAERS
58Medication ErrorFAERS: 1US FAERS
59Neck PainFAERS: 1US FAERS
60Nerve injuryFAERS: 1US FAERS
61Nonspecific reactionFAERS: 1US FAERS
62Open woundFAERS: 1US FAERS
63Oral mucosal erythemaFAERS: 1US FAERS
64Oropharyngeal painFAERS: 1US FAERS
65Otitis ExternaFAERS: 1US FAERS
66OverdoseFAERS: 1US FAERS
67Product packaging confusionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
68Product use issueFAERS: 1US FAERS
69StomatitisFAERS: 1US FAERS
70Unevaluable eventFAERS: 1US FAERS
71Wrong product administeredFAERS: 1US FAERS
72Wrong technique in product usage processFAERS: 1US FAERS
73Ear dischargeOFFSIDES
74Eye BurnsCanada Vigilance: 1Canada Vigilance
75Nervous tensionOFFSIDES
76Product label confusionCanada Vigilance: 1Canada Vigilance
77Product selection errorCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.